From: Growth impairment in children with atrophic autoimmune thyroiditis and pituitary hyperplasia
Patients | TSH, mUI/ml (nv 0.27–4.2) | FT4, pmol/l (nv 12–22) | TPOAb, IU/ml (nv 0–34) | TGAb, IU/ml (nv 0-115) | IGF-1, ng/ml | PRL, uUI/ml (nv 86–496) | E2, pg/ml (pv < 12) | TEST, ng/dl (pv < 20) | Pituitary Volume, mm3 |
---|---|---|---|---|---|---|---|---|---|
Patient 1 | 236.6 | 3.2 | 3486 | 200 | 53.6 | 214 | 13 | NA | 650 |
Patient 2 | 319 | 2.79 | 4580 | 289 | 88.5 | 497 | 5 | NA | 648,9 |
Patient 3 | 1214 | 1.03 | 597 | 1805 | 73.1 | 999 | 12.4 | NA | 514,8 |
Patient 4 | 962 | 5.5 | 1185.8 | 554.8 | 112 | 659.5 | NA | NA | 1830 |
Patient 5 | 1000 | 5.5 | 88.8 | 15.5 | 120.3 | 723.4 | NA | NA | 1965 |
Patient 6 | 1000 | 1.93 | 187.6 | 36.8 | 123.3 | 1362 | NA | NA | 1419,6 |
Patient 7 | 359.5 | 6.17 | 383.6 | 416.9 | 93.6 | 434 | NA | NA | 532,48 |
Patient 8 | 1648 | 3 | 1020 | 2040 | NA | NA | NA | NA | 1123 |
Patient 9 | 1113 | 4.3 | 1020 | 2040 | 55.8 | 838.2 | 20 | NA | 1514 |
Patient 10 | 324 | 0.5 | 98 | 31 | 201 | 255 | NA | 25 | 504 |
Patient 11 | 750 | 3.9 | 168 | 391 | NA | 485.8 | 16.4 | 418 | 3528 |
Patient 12 | 1016 | 4 | 296.4 | NA | 76.8 | 835.8 | NA | NA | 770 |